D. Mark Bickett
GlaxoSmithKline (United States) · 27 works · 1,250 citations · h-index 15
Top works
- A High Throughput Fluorogenic Substrate for Interstitial Collagenase (MMP-1) and Gelatinase (MMP-9)
- Metalloproteinase Inhibitors for the Disintegrin-Like Metalloproteinases ADAM10 and ADAM17 that Differentially Block Constitutive and Phorbol Ester-Inducible Shedding of Cell Surface Molecules
- Substrate Specificity of Human Collagenase 3 Assessed Using a Phage-displayed Peptide Library
- Matrix Metalloproteinase Inhibitors Containing a [(Carboxyalkyl)amino]zinc Ligand: Modification of the P1 and P2' Residues
- Characterization of the peptide substrate specificities of interstitial collagenase and 92-kDa gelatinase. Implications for substrate optimization
- Structural features and biochemical properties of TNF-α converting enzyme (TACE)
- Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE)
- Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.
- Structural features required for inhibition of cyanide-insensitive electron transfer by propyl gallate
- Structure-Activity Relationships for Inhibition of Type 1 and 2 Human 5.alpha.-Reductase and Human Adrenal 3.beta.-Hydroxy-.DELTA.5-steroid Dehydrogenase/3-Keto-.DELTA.5-steroid Isomerase by 6-Azaandrost-4-en-3-ones: Optimization of the C17 Substituent
- N-Hydroxyformamide peptidomimetics as TACE/Matrix metalloprotease inhibitors: oral activity via P1′ isobutyl substitution
- Rapid synthesis of novel dipeptide inhibitors of human collagenase and gelatinase using solid phase chemistry
- Inhibition of Tumor Necrosis Factor-α (TNF-α) Production and Arthritis in the Rat by GW3333, a Dual Inhibitor of TNF-α-Converting Enzyme and Matrix Metalloproteinases
- Substrate Specificity and Novel Selective Inhibitors of TNF-α Converting Enzyme (TACE) from Two-Dimensional Substrate Mapping
- Binding of Butyl Gallate to Isolated Mung Bean Mitochondria
- [3] Defined substrate mixtures for mapping of proteinase specificities
- A High Throughput Fluorogenic Substrate for Stromelysin (MMP‐3)
- TNFα converting enzyme
- Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy
- Erratum: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α